Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis

NCT01154153 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial and/or Seasonal

Interventions

DRUG: Placebo nasal spray
DRUG: Triamcinolone acetonide aqueous (TAA-AQ) nasal spray (NASACORT AQ)
DRUG: Placebo nasal spray
DRUG: Claritin® Syrup

Sponsor

Sanofi